Rajiv Sondhi
CEO | Open ANA
Rajiv Sondhi is a seasoned technology executive and transformational leader with extensive experience in driving digital innovation, enterprise modernization, and AI-led business transformation across global organizations. With a strong background in enterprise architecture, cloud, cybersecurity, data, and emerging technologies, he has led large-scale transformation initiatives spanning healthcare, manufacturing, automotive, and digital enterprises.
Recognized for his strategic vision and execution excellence, Rajiv brings deep expertise in aligning technology with business outcomes, enabling organizations to accelerate innovation, improve operational resilience, and unlock new growth opportunities. His thought leadership spans areas such as AI-driven transformation, infrastructure modernization, cybersecurity, enterprise platforms, and technology due diligence.
Over the course of his career, Rajiv has worked closely with CXOs and global enterprises to navigate complex technology landscapes, modernize digital ecosystems, and build scalable, future-ready organizations. He is also an active contributor to industry forums and advisory initiatives focused on AI, digital enterprise transformation, and emerging technologies.
Rajiv is passionate about shaping the future of intelligent enterprises through innovation, responsible AI adoption, and technology-led business reinvention.
All Sessions by Rajiv Sondhi
Engineering Theatre
AI‑Native Digital Thread for MedTech: From Code Traceability to Material DNA
Two years ago, a regulatory crisis forced a different question — not how to automate compliance, but how to amplify the experts who understand it. The more you automate with black-box AI, the more you erode the expertise regulators demand. ThELix OS resolves that tension: autonomous agents handling the workflow, domain experts governing every decision.
Two acts. One platform.
ViTel™ transforms fragmented material records, supplier data, and compliance obligations into a living Material DNA layer across the product lifecycle. AnaTel™ reimagines not retrofits — how regulated software is built: FDA submission acceleration, bidirectional traceability, and clinical evidence intelligence.
Real outcomes: 70% reduction in regulatory research labor. 60% reduction in clinical review effort. 72 hours versus eight weeks on SaMD change assessment.
Compliance is not the opposite of competitive advantage. Done right, it is the source of it.
For: Engineering, regulatory, QA, and digital health leaders in medical device and SaMD organizations.
Resources
Subscribe to MassDevice
Advertise with us
For registration or logistic questions, contact events@wtwhmedia.com
Sponsorship Opportunities
Colleen Sepich
Events Sales Director
csepich@wtwhmedia.com
857-260-1360
Heather Herbert
Event Sales Manager
hherbert@wtwhmedia.com
512-760-0570